NCT03418623View on ClinicalTrials.gov

Effect of GET73 on MRS Measures of Central Glutamate and GABA in Individuals With Alcohol Use Disorder

PHASE2CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 8, 2018

Primary Completion Date

March 13, 2020

Study Completion Date

March 13, 2020

Conditions
Alcohol Use Disorder
Interventions
DRUG

GET73

GET73 300 mg oral capsules, administered three times a day on Visit 2 and 4, and twice a day on Visit 3 and 5.

OTHER

Placebo

Placebo oral capsules, administered three times a day on Visit 2 and 4, and twice a day on Visit 3 and 5.

Trial Locations (1)

29425

Department of Psychiatry and Behavioral Sciences - Medical University of South Carolina, Charleston

Sponsors
All Listed Sponsors
collaborator

Latis S.r.l.

INDUSTRY

lead

Laboratorio Farmaceutico Ct S.r.l.

INDUSTRY

NCT03418623 - Effect of GET73 on MRS Measures of Central Glutamate and GABA in Individuals With Alcohol Use Disorder | Biotech Hunter | Biotech Hunter